KRAS and cholangiocarcinoma: Recently, heterozygous and homozygous deletion of PTEN locus in presence of KRAS activation was demonstrated to induce intrahepatic cholangiocarcinoma in cholangiocytes of a new mouse model32 showing an important role of PTEN in the development of this tumour type.